Cancer Policy Vinay Prasad regains role as FDA chief medical and scientific officer September 12, 2025Vol.51 No.33By Claire Marie Porter
Cancer Policy FDA advances rare disease drug development with new evidence principles September 12, 2025Vol.51 No.33By Jacquelyn Cobb
Cancer Policy As House committee gives NIH a small raise, cancer groups hope to maintain bipartisan support September 12, 2025Vol.51 No.33By Claire Marie Porter
Cancer Policy The departure (and return) of Vinay Prasad September 05, 2025Vol.51 No.32By Claire Marie Porter
Cancer Policy Trump administration wants to rebuild stockpile of APIs to address drug shortages September 05, 2025Vol.51 No.32By Sara Willa Ernst
Cancer Policy Trump administration unlawfully terminated grants from Harvard, federal judge rules September 05, 2025Vol.51 No.32By Sara Willa Ernst
Cancer Policy FDA will speed up public release of Complete Response Letters September 05, 2025Vol.51 No.32By Sara Willa Ernst
Cancer PolicyFree ACOG says it will no longer accept federal funding August 08, 2025Vol.51 No.31By Claire Marie Porter
Cancer PolicyFree Trump administration broke law by canceling DEI research grants, GAO finds August 08, 2025Vol.51 No.31By Jacquelyn Cobb
Cancer PolicyFree HHS halts nearly $500M in mRNA-related vaccine contracts August 08, 2025Vol.51 No.31By Claire Marie Porter
